GUINEA-PIG AND HUMAN CYTOMEGALOVIRUSES DO NOT SHARE CROSS-REACTIVE NEUTRALIZING EPITOPES

被引:3
作者
ADLER, SP [1 ]
SHAW, KV [1 ]
MCVOY, M [1 ]
BURKE, RL [1 ]
LIU, H [1 ]
机构
[1] CHIRON CORP,EMERYVILLE,CA 94608
关键词
HUMAN AND GUINEA PIG CYTOMEGALOVIRUS; NEUTRALIZING ANTIBODIES; CROSS-REACTIVITY;
D O I
10.1002/jmv.1890470110
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human (HCMV) and guinea pig (gpCMV) cytomegaloviruses share biological similarities and DNA sequence homologies. Therefore, human and guinea pig sera were tested for crossreactive antibodies. In eight human sere (four HCMV-seropositive and four HCMV-seronegative), low levels of neutralizing activity against gpCMV were not associated with antibodies to HCMV. The convalescent sera of one of three humans infected with either HCMV Towne vaccine or wild-type HCMV developed a fourfold increase in neutralizing titers to gpCMV after infection, but none of seven guinea pigs immunized with either HCMV Towne or purified HCMV gB developed neutralizing activity against gpCMV. Guinea pigs immunized with gpCMV did not develop antibodies to HCMV or human gB. Neither gpCMV, HCMV Towne stain or purifled HCMV gB induced cross-reactive antibodies against the heterologous virus as detected by enzyme immunoassay. Our results indicate that gpCMV and HCMV share a very limited number, if any, of cross-reactive neutralizing epitopes. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:48 / 51
页数:4
相关论文
共 15 条
[1]   IMMUNITY INDUCED BY PRIMARY HUMAN CYTOMEGALOVIRUS-INFECTION PROTECTS AGAINST SECONDARY INFECTION AMONG WOMEN OF CHILDBEARING AGE [J].
ADLER, SP ;
STARR, SE ;
PLOTKIN, SA ;
HEMPFLING, SH ;
BUIS, J ;
MANNING, ML ;
BEST, AM .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :26-32
[2]   DETECTION OF CYTOMEGALOVIRUS ANTIBODY BY ENZYME-IMMUNOASSAY AND LACK OF EVIDENCE FOR AN EFFECT RESULTING FROM STRAIN HETEROGENEITY [J].
ADLER, SP ;
MCVOY, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (05) :870-872
[3]   VACCINATION AGAINST TRANS-PLACENTAL CYTOMEGALOVIRUS TRANSMISSION - VACCINE REACTIVATION AND EFFICACY IN GUINEA-PIGS [J].
BIA, FJ ;
MILLER, SA ;
LUCIA, HL ;
GRIFFITH, BP ;
TARSIO, M ;
HSIUNG, GD .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (03) :355-362
[4]   VACCINATION FOR THE PREVENTION OF MATERNAL AND FETAL INFECTION WITH GUINEA-PIG CYTOMEGALO-VIRUS [J].
BIA, FJ ;
GRIFFITH, BP ;
TARSIO, M ;
HSIUNG, GD .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (05) :732-738
[5]   CELL-SURFACE EXPRESSION OF HUMAN CYTOMEGALOVIRUS (HCMV) GP55-116 (GB) - USE OF HCMV-RECOMBINANT VACCINIA VIRUS-INFECTED CELLS IN ANALYSIS OF THE HUMAN NEUTRALIZING ANTIBODY-RESPONSE [J].
BRITT, WJ ;
VUGLER, L ;
BUTFILOSKI, EJ ;
STEPHENS, EB .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1079-1085
[6]   THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS [J].
FOWLER, KB ;
STAGNO, S ;
PASS, RF ;
BRITT, WJ ;
BOLL, TJ ;
ALFORD, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :663-667
[7]   A MULTIGENE FAMILY ENCODES THE HUMAN CYTOMEGALO-VIRUS GLYCOPROTEIN COMPLEX GCII (GP47-52 COMPLEX) [J].
GRETCH, DR ;
KARI, B ;
GEHRZ, RC ;
STINSKI, MF .
JOURNAL OF VIROLOGY, 1988, 62 (06) :1956-1962
[8]  
GRIFFITH BP, 1991, TRANSPLANT P, V23, P29
[9]   CHARACTERIZATION OF GUINEA-PIG CYTOMEGALOVIRUS DNA [J].
ISOM, HC ;
GAO, M ;
WIGDAHL, B .
JOURNAL OF VIROLOGY, 1984, 49 (02) :426-436
[10]   IMMUNE-RESPONSE TO GUINEA-PIG CYTOMEGALOVIRUS POLYPEPTIDES AND CROSS-REACTIVITY WITH HUMAN CYTOMEGALOVIRUS [J].
KACICA, MA ;
HARRISON, CJ ;
MYERS, MG ;
BERNSTEIN, DI .
JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (03) :155-159